When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 2, 2009.

Where is the headquarters located?

The headquarters is located at: Ametystowa 2, 20-577 Lublin.

What is the share capital?

The share capital of the company is PLN 60,000 (approx. $16,207).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2019 to December 31, 2019.

How much revenue was generated?

In 2019, the company generated total revenue of $735,034, representing a decrease of 61.0% compared to 2018.

No, in 2019 the company was not profitable, reporting a net loss of $63,225. For comparison, in 2018 the loss was $40,678, meaning the company increased its loss by 65.2%.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $605,768 in 2019, representing 78% of all operating expenses.

Meapharmsp. z o.o.

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2009-03-02

Share capital

60,000.00 PLN

Registered address

Ametystowa 2/5, 20-577 Lublin, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2020 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 269 days for 2018).

2020not filed
201931/10/2020
201809/04/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2019.

Results vs industry

Revenue

This companyUSD 735.03kMedianUSD 445.76kAverageUSD 397.33k

Net profit

This companyUSD -63.23kMedianUSD -13.20kAverageUSD -7.39k

Operating costs

This companyUSD 777.35kMedianUSD 364.44kAverageUSD 388.73k

Assets

This companyUSD 312.97kMedianUSD 256.23kAverageUSD 190.36k

Industry

Authorized Representatives

Anna Kijewska – President

Manner of representation

In the case of a multi-member management board, making declarations of will and signing on behalf of the company requires the joint action of 2 (two) members of the management board or 1 (one) member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Anna Kijewskaage 54	40	$10,804.97	66.6667%
Wanda Wieczorek	20	$5,402.49	33.3333%

Beneficial owners

Person	Rights

Subsidiaries

	Name	Share value	Stake
	Medi Pharmasp. z o.o.	6,753.11 USD	100%

Bank accounts

Registered as a VAT taxpayer on 2006-10-07.

No bank accounts reported to the VAT Taxpayer Register.

Debt

3 closed proceedings recorded in KRZ history.

Registration date	Proceeding type	Status
Apr 15, 2025	Discontinued enforcement proceedings	Closed
Dec 6, 2023	Discontinued enforcement proceedings	Closed
Oct 27, 2023	Discontinued enforcement proceedings	Closed

MSiG notices

Publication date	Event
Sep 21, 2026	Dissolution without liquidation opened
Aug 12, 2022	Dissolution without liquidation opened

Public aid

Grant date	Purpose	Gross amount	Granting body
Jan 15, 2019	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$3,648$3,648	Prezes Zakładu Ubezpieczeń Społecznych

Competitors

Name	Revenue	Website
Biomarsp. z o.o.	$909,113.28	biomar.pl
Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o.	$893,738.50	lekinatury.pl
Human BiomeS.A.	$888,361.19	human-biome.com
Zeptor Polskasp. z o.o.	$748,374.79	zeptor.pl
Natur DayS.A.	$680,635.59	naturday.pl
Biotriosp. z o.o.	$453,662.22	biotrio.pl
DR Andresp. z o.o.	$453,987.42	drandre.pl
STEM Cells SpinS.A.	$287,714.76	stemcellsspin.com.pl
Pexon Polandsp. z o.o.	$122,615.96	pexon.pl
Powerpharmasp. z o.o.	–	powerpharma.eu